| Titre : | Acryloylfentanyl. Report on the risk assessment of N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances |
| Auteurs : | OEDT = EMCDDA |
| Type de document : | Rapport |
| Editeur : | Lisbon : OEDT / EMCDDA, 2017 |
| Autre Editeur : | Luxembourg : Publications Office of the European Union |
| Collection : | Risk assessments, ISSN 1725-4493, num. 20 |
| ISBN/ISSN/EAN : | 978-92-9497-239-2 |
| Format : | 50 p. |
| Langues: | Anglais |
| Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
| Mots-clés : |
Organismes OEDTThésaurus mots-clés FENTANYL ; CONTROLE DES STUPEFIANTS ; FACTEUR DE RISQUE ; DROGUES DE SYNTHESE ; PHARMACOLOGIE ; TYPE D'USAGE ; EFFET SECONDAIRE ; TOXICITE ; INTOXICATION ; MORTALITEThésaurus géographique EUROPE |
| Résumé : | This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of the Risk Assessment Report - and on the initiative of the European Commission - on 25 September 2017, the Council decided that acryloylfentanyl should be subject to control measures across the Member States. |
| Note de contenu : |
TABLE OF CONTENTS:
Foreword. EMCDDA actions on monitoring and responding to new drugs. EMCDDA-Europol Joint Report on acryloylfentanyl: a summary. Risk Assessment Report of a new psychoactive substance: acryloylfentanyl. Annex 1: Technical report on acryloylfentanyl. Council Decision on subjecting acryloylfentanyl to control measures. Participants of the risk assessment meeting. |
| Domaine : | Drogues illicites / Illicit drugs |
| Lien : | http://www.emcdda.europa.eu/publications/risk-assessments/acryloylfentanyl_en |
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Documents numériques (1)
 EMCDDA_Acryloylfentanyl_2017.pdf Adobe Acrobat PDF |
Accueil
